IDEAYA Reports Q3 2026 Net Loss of $125.7 Million
IDEAYA reported $10.2 million in collaboration revenue and ended September with $1.15 billion in cash, cash equivalents and marketable securities. It maintained its cash runway guidance into 2030 and completed an NDA submission for darovasertib.
IDEAYA reported a third-quarter 2026 net loss of $125.7 million, with collaboration revenue of $10.2 million. The company ended September with $1.15 billion in cash, cash equivalents and marketable securities, and maintained its cash runway guidance into 2030. IDEAYA also completed an NDA submissio…